|
|
|
|
|
|
|
|
|
9¿ù Cancer Newsletter ¼Ò½Ä
- Human High
Performance Cytokine Discovery Panel Ãâ½Ã!
- PI3K-AKT Signaling
Poster
Sign up here for other newsletters.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Luminex High Performance Cytokine 45-Plex!
R&D Systems¿¡¼ Human XL Cytokine Discovery PanelÀÌ »õ·Ó°Ô Ãâ½ÃµÇ¾ú½À´Ï´Ù. ÃÑ 45°³ÀÇ analytes¸¦ Çѹø¿¡ È®ÀÎÀÌ °¡´ÉÇϸç, customizeÇÏ¿© °ü½É analyte¸¸ È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù. R&D SystemsÀÇ Human XL Cytokine Discovery PanelÀ» Áö±Ý È®ÀÎÇغ¸¼¼¿ä!
|
|
|
|
|
|
VSIG-3/IGSF11 is a Ligand of VISTA/PD-1H and
Inhibits Human T Cell Function
ÀÌ ¿¬±¸¿¡ µû¸£¸é, VSIG-3/IGSF11ÀÌ human T cell ±â´ÉÀ» ¾ïÁ¦ÇÏ´Â B7 family member VISTA/PD-1HÀÇ ligand¶ó´Â
°ÍÀÌ È®ÀεǾú½À´Ï´Ù. Download Now!
|
|
|
|
|
|
A Role for VSIG-3/VISTA Signaling in Acquired
Resistance to Anti-PD-1 Therapy?
ÃàÀüµÈ data¸¦ Åä´ë·Î VISTA/VSIG-3
co-inhibitory pathway°¡ metastatic
melanoma¿¡¼ PD-1 checkpoint inhibition¿¡ ´ëÇÑ ³»¼ºÀ»
±Øº¹Çϱâ À§ÇÑ potential therapeutic targetÀÓÀ» º¸¿©µå¸³´Ï´Ù. Learn More!
|
|
|
|
|
|
BTN1A1 Acts as a Co-Inhibitory Molecule on T
Cells
ButyrophilinsÀº immune checkpoint regulatorsÀÇ »õ·Î¿î subsetÀÏ °ÍÀ¸·Î ÃßÃøµË´Ï´Ù. ±× ±Ù°Å·Î R&D
Systems¿¡¼´Â BTN1A1ÀÌ T cells¿¡ co-inhibitory
molecule·Î ÀÛ¿ëÇÑ´Ù´Â data¸¦ È®ÀÎÇغ¸¼¼¿ä. Learn More!
|
|
|
|
|
|
Are Butyrophilins Worthwhile Cancer Biomarker
Candidates?
cancer¿¡ °ü·ÃÇÏ¿© Butyrophilin transcriptsÀÇ º¯ÀÌµÈ ¹ßÇö¿¡ µû¶ó co-stimulatory/co-inhibitory molecules
ÀÌ Á¸ÀçÇÏ´Â °Í ¿Ü¿¡µµ, ButyrophilinsÀº °¡Ä¡ ÀÖ´Â cancer biomarker candidates ¶Ç´Â drug targetsÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Learn More!
|
|
|
|
|
|
Proteome Profiler Human XL Cytokine Array Kit
1 °³ÀÇ sample¿¡¼ 105 °³ÀÇ ´Ù¾çÇÑ
cyotokine°ú chemokinesÀ» ¼Õ½±°Ô ÃøÁ¤Çϼ¼¿ä. ÀÌ Kit´Â cell culture supernates, cell lysates, tissue lysates,
serum, plasma, human milk, ±×¸®°í saliva¿¡ ´ëÇØ validationµÇ¾î ÀÖ½À´Ï´Ù. Ưº°ÇÑ Àåºñ°¡ ÇÊ¿äÇÏÁö ¾ÊÀ¸¸ç chemiluminescent ¹× LI-COR detection°ú ȣȯµË´Ï´Ù. Learn More!
|
|
|
|
|
|
Economical DuoSet ELISA Development Systems for
Cancer Immunotherapy
DuoSet ELISA Development SystemsÀº sandwich ELISA¸¦ °³¹ßÇϱâ À§ÇÑ ±âº» ±¸¼º ¿ä¼Ò ¹× ÇÔ²² Á¦°øµÇ´Â antibody pairs¿Í ÀÏÄ¡ÇÕ´Ï´Ù. PD-1, PD-L1/B7-H1, LAG-3, TIM-3, HVEM, GITR, PD-L2/B7-DC, B7-1/CD80, 4-1BB/TNFRSF9 , ±×¸®°í CD27/TNFRSF7 µî ´Ù¾çÇÑ targetsÀ» È®ÀÎÇغ¸¼¼¿ä.
|
|
|
|
|
|
PSB 12379: A New CD73 Inhibitor From Tocris
CD73Àº lymphocytes¿Í tumor cells¿¡¼ ¹ß°ßµÇ´Â cell surface phosphatase·Î extracellular
adenosineÀ» »ý¼ºÇÏ¿©, tumor-infiltrating immune cellsÀÇ immunosuppressionÀ» À¯µµÇÕ´Ï´Ù. TocrisÀÇ ¼±ÅÃÀû high affinity
inhibitorÀÎ PSB 12379·Î CD73ÀÇ ¿ªÇÒÀ» È®ÀÎÇغ¸¼¼¿ä.
|
|
|
|
|
|
PI3K-AKT Signaling - NEW Wall Poster
Novus¿¡¼ ¸¸µç PI3K-AKT
Signaling Poster¸¦ ÅëÇØ ÇØ´ç signaling¿¡ °ü¿©ÇÏ´Â Áß¿äÇÑ moleculeµé °£ÀÇ interactionÀ» È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù! Request a print copy!
|
|
|
|
Bio-Techne at
Upcoming Meetings
|
|
1st Crick International Cancer
Conference
London, UK, September 24-26 2017
3rd International Symposium of
the Cancer Research Center of Lyon
Lyon, France, September 25-27, 2017
3rd Annual Cell and Gene Therapy
Congress 2017
London, UK, November 6-7, 2017
PEGS Europe 2017
Lisbon, Portugal, November 13-17, 2017
Autumn Immunology Conference
Chicago, USA, November 17-20, 2017
Cell Therapy Manufacturing and
& Gene Therapy 2017
Amsterdam, Netherlands, December 6-7, 2017
2017 Cell & Gene Therapy
World
Miami, USA, January 23-25, 2018
13th Biomarker Congress 2018
Manchester, UK, February 15-16, 2018
2018 American Association for
Cancer Research
Chicago, USA, April 14-18, 2018
British Society for Gene and Cell
Therapy (BSGCT) Annual Conference 2018
London, UK, April 27, 2018
25th Biennial Congress of the
European Association for Cancer Research (EACR)
Amsterdam, Netherlands, June 30-July 3, 2018
|
|
|
|
|
|
|
|
Have a product
suggestion? Let us know here!
|
|
|
|
|
|
|
